CHTN VUMC, Canada

Registration Status: Pending

Objective: VUMC-CHTN is primarily funded by the National Cancer Institute as a human surgical and autopsy remnant tissue procurement facility. Federal funds support less than 25% of operational costs with the other 75% of costs being recouped via services. The biorepository operates under a waiver of consent and also consents participants for use of remnant tissue and biofluid collection. Academic and commercial investigators with R&D protocols are encouraged to apply. We are not subsidized to support clinical trials.

Registered Biobank Name CHTN VUMC
Biobank Leader Kerry Wiles
Country Canada
Email for biobank inquiries kerry.wiles@vumc.org
Principal Investigator Dr. Mary Kay Washington
Website
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected: